Get the Stockscreener App
10.81
3.31%
-0.37
After Hours:
10.81
Integra Lifesciences Holdings Corp stock is traded at $10.81, with a volume of 1.15M.
It is down -3.31% in the last 24 hours and down -17.79% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$11.18
Open:
$11.19
24h Volume:
1.15M
Relative Volume:
1.50
Market Cap:
$842.01M
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
21.62
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
-0.64%
1M Performance:
-17.79%
6M Performance:
-21.50%
1Y Performance:
-55.11%
1-Day Range:
$10.69
$11.33
1-Week Range:
$10.60
$11.49
52-Week Range:
$10.60
$25.45
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
10.81 | 870.83M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Is Integra LifeSciences Holdings Corporation stock influenced by commodity prices2025 Risk Factors & Accurate Technical Buy Alerts - mfd.ru
Integra LifeSciences stock faces scrutiny after Reuters report on TruDi system - Investing.com
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 - Yahoo Finance
Investors in Integra LifeSciences Holdings (NASDAQ:IART) have unfortunately lost 84% over the last five years - Yahoo Finance
[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Bank Watch: Will NANO Nuclear Energy Inc outperform small cap indexes2025 Fundamental Recap & Real-Time Volume Triggers - baoquankhu1.vn
Aug Patterns: What is the earnings history of Integra LifeSciences Holdings CorporationQuarterly Growth Report & Growth Focused Investment Plans - baoquankhu1.vn
Earnings Risk: Will Integra LifeSciences Holdings Corporation benefit from geopolitical trends2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What's Going On With Integra LifeSciences Stock Friday?Integra Lifesciences (NASDAQ:IART) - Benzinga
FDA Alert Targets Integra LifeSciences' MediHoney Wound Products - GuruFocus
Aug Decliners: Is Integra LifeSciences Holdings Corporation a cyclical or defensive stockJuly 2025 Retail & Weekly Hot Stock Watchlists - baoquankhu1.vn
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $15.00 Average PT from Brokerages - Defense World
Integra LifeSciences Holdings C (IART): Investor Outlook With A 17.87% Potential Upside - DirectorsTalk Interviews
Is Integra LifeSciences Holdings Corporation stock a good choice for value investorsJuly 2025 Drop Watch & Consistent Profit Trading Strategies - Улправда
Is Integra LifeSciences Holdings Corporation stock affected by interest rate hikesJuly 2025 Fed Impact & Safe Entry Zone Tips - ulpravda.ru
Bear Alert: Is Integra LifeSciences Holdings Corporation stock affected by interest rate hikesTrade Exit Report & Short-Term Swing Trade Alerts - Улправда
Aug Ideas: How Integra LifeSciences Holdings Corporation (IL3) stock performs in easing cyclesMarket Activity Report & High Accuracy Investment Entry Signals - ulpravda.ru
How buybacks impact Integra LifeSciences Holdings Corporation stock valueMarket Performance Summary & Consistent Profit Alerts - ulpravda.ru
Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 23.41% Potential Upside Amidst Challenges - DirectorsTalk Interviews
Integra LifeSciences to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
3 Reasons to Sell IART and 1 Stock to Buy Instead - Yahoo Finance
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Quantisnow
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? - Yahoo Finance
Will Integra LifeSciences Holdings Corporation stock keep outperforming rivalsTrade Exit Summary & Real-Time Volume Triggers - Улправда
What Wall Street predicts for Integra LifeSciences Holdings Corporation stock price - Улправда
How geopolitical tensions affect Integra LifeSciences Holdings Corporation stockMarket Growth Summary & Weekly Return Optimization Plans - Улправда
How Integra LifeSciences Holdings Corporation (IL3) stock reacts to fiscal policiesJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Why Integra LifeSciences Holdings Corporation stock is considered a top pickPortfolio Update Summary & Fast Gaining Stock Reports - DonanımHaber
How supply shortages influence Integra LifeSciences Holdings Corporation (IL3) stockWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Is Integra LifeSciences Holdings Corporation stock resilient to inflation2025 Key Highlights & Community Verified Watchlist Alerts - Улправда
What valuation multiples suggest for Integra LifeSciences Holdings Corporation stockJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Why Integra LifeSciences Holdings Corporation (IL3) stock is favored by hedge fundsWeekly Market Report & Consistent Profit Alerts - DonanımHaber
Why Integra LifeSciences Holdings Corporation stock could outperform in 2025 - Улправда
Will Integra LifeSciences Holdings Corporation stock maintain dividend yield2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools - Kalkine Media
Is Integra LifeSciences (IART) Undervalued After Its Recent Share Price Rebound? - simplywall.st
Integra LifeSciences (NASDAQ: IART) adopts renewed CIC severance plan - Stock Titan
Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars - setenews.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes - simplywall.st
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):